8 Recruiting Diffuse Large B Cell Lymphoma Phase 2 Clinical Trials
Active phase 2 studies for diffuse large b cell lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Diffuse Large B Cell Lymphoma studiesPhase 2 Studies for Diffuse Large B Cell Lymphoma
🔵 Active, Not Recruiting Phase1 / Phase2
Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients
📍 Morristown Memorial Hospital — Morristown, New Jersey
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Copanlisib Plus Venetoclax in R/R DLBCL
📍 City of Hope Cancer Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Split-Dose R-CHOP for Older Adults With DLBCL
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2
TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
📍 Rhode Island Hospital — Providence, Rhode Island
View Study & Checklist ➔ 🟢 Recruiting Phase2
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
📍 Goshen Center for Cancer Care — Goshen, Indiana
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase2
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔